8-K

===========================================================================

                          UNITED STATES
                 SECURITIES AND EXCHANGE COMMISSION
                       Washington, D.C. 20549
                            __________

                             FORM 8-K

                         CURRENT REPORT

  Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

    Date of Report (Date of earliest event reported): February 1, 2005


                        PETMED EXPRESS, INC.
         ----------------------------------------------------
        (Exact name of registrant as specified in its charter)

                 Commission file number 000-28827
                                        ---------

            FLORIDA                         65-0680967
    ---------------------------            ------------
   (State or other jurisdiction           (IRS Employer
of incorporation or organization)	Identification No.)


1441 S.W. 29th Avenue, Pompano Beach, Florida     33069
 --------------------------------------          --------
(Address of principal executive offices)	(Zip Code)

Registrant's telephone number, including area code: (954) 979-5995
                                                    --------------

                        Not Applicable
   -----------------------------------------------------------
  (Former name or former address, if changed since last report)



Check the appropriate box below if the Form 8-K is intended to
simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:

[ ] Written communications pursuant to Rule 425 under the Securities Act

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under
    the Exchange Act

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under
    the Exchange Act







Item 7.01  Regulation FD Disclosure

    On February 1, 2005, PetMed Express, Inc. issued a press release
announcing the dismissal of the class action suits.  A copy of this
press release is attached hereto as Exhibit 99.1 and is incorporated
herein by reference.

    The information furnished in this Item 9, intended to be
furnished under Item 12, is instead furnished under Item 9 in
accordance with SEC Release 33-8216.  This information shall not be
deemed "filed" for purposes of Section 18 of the Securities Exchange
Act of 1934, as amended (the "Exchange Act") nor shall such
information be incorporated by reference in any filing under the
Securities Act of 1933, as amended, or the Exchange Act, except as
shall be expressly set forth by specific reference in such filing.

Item 9.01  Financial Statements and Exhibits

           (c)  Exhibits

99.1	Press Release issued by PetMed Express, Inc. on February 1, 2005







                              SIGNATURES


    Pursuant to the requirements of the Securities Exchange Act of
1934, the Registrant has duly caused this report to be signed on its
behalf by the undersigned hereunto duly authorized.


PETMED EXPRESS, INC.
(The "Registrant")

Date: February 2, 2005

By: /s/  Menderes Akdag
    -------------------------
    Menderes Akdag

    Chief Executive Officer
    (principal executive officer)

By: /s/  Bruce S. Rosenbloom
    -----------------------------
    Bruce S. Rosenbloom

    Chief Financial Officer
    (principal financial and accounting officer)







                          EXHIBIT INDEX

Exhibit No.    Description


99.1	Press Release issued by PetMed Express on February 1, 2005

EX-99.1

                            EXHIBIT 99.1

Date:      February 1, 2005
Contact:   Bruce S. Rosenbloom, CFO
Phone:     (954) 979-5995
Fax:       (954) 971-0544

PETMED EXPRESS D/B/A 1-800-PETMEDS ANNOUNCES THE DISMISSAL OF CLASS
ACTION SUITS

Pompano Beach, Florida, February 1, 2005 - PetMed Express, Inc.
(NASDAQ: PETS) is pleased to announce that the six consolidated
supposed class action suits against PetMed Express and several of its
officers were voluntarily dismissed today by the plaintiffs.  PetMed
Express has maintained from the inception of these suits that they
were clearly without merit.  With this dismissal, it is apparent that
the plaintiffs now agree.  The Company welcomes the removal of this
distraction so that it can continue to focus on its business goals.

Founded in 1996, PetMed Express is America's largest pet pharmacy,
delivering prescription and non-prescription pet medications and other
health products for dogs and cats at competitive prices direct to the
consumer through its 1-800-PetMeds toll free number and on the
Internet through its website at www.1800PetMeds.com.
                                -------------------

This press release may contain "forward-looking" statements, as
defined in the Private Securities Litigation Reform Act of 1995 or by
the Securities and Exchange Commission, that involve a number of risks
and uncertainties, including the Company's ability to meet the
objectives included in its business plan.  Important factors that
could cause results to differ materially from those indicated by such
"forward-looking" statements are set forth in Management's Discussion
and Analysis of Financial Condition and Results of Operation in the
PetMed Express Annual Report on Form 10-K for the year ended March 31,
2004.  The Company's future results may also be impacted by other risk
factors listed from time to time in its SEC filings, including, but
not limited to, the Company's Form 10-Q and its Annual Report on Form
10-K.

For investment relations contact PetMed Express, Inc., Pompano Beach,
Bruce S. Rosenbloom, CFO, 954-979-5995.



                                 ###

                           99.1 page 1 - 1